Mengukur Kinerja Keuangan Menggunakan Eva dan Rasio Aktivitas Pada Industri Farmasi Setelah Holding BUMN
DOI:
https://doi.org/10.47065/arbitrase.v4i1.1052Keywords:
Financial Performance; EVA; Activity RatioAbstract
A company's financial performance, as based on value-added, can indicate its capacity to enhance the well-being of investors or shareholders. One of the notable accomplishments of firm management in financial management is the attainment of efficient financial performance through the optimal utilisation of company resources. This study aimed to measure the financial performance of the pharmaceutical industry after holding BUMN, utilising the EVA and activity ratios as measurement instruments. This study employed a descriptive analysis methodology to depict a symptom or scenario in its current state during this research without engaging in hypothesis testing. The study was conducted at PT Kimia Farma Tbk and PT Indonesia Farma Tbk, publicly listed on the Indonesia IDX. This data was selected using the documentation method and was analysed using EVA and Efficiency Ratio analysis instruments. The findings indicated that PT Indofarma Tbk financial performance could generate value added after holding BUMN in 2020 and 2021. On the one hand, PT Kimia Farma Tbk demonstrated the creation of value added after holding BUMN in 2021 and 2022. In addition, the findings indicated that the operational efficiency of PT Indofarma and PT Kimia Farma Tbk improved significantly after holding BUMN in 2021, as revealed by their enhanced financial performance.
Downloads
References
Atmaja, M. Y. H., & Arthink, D. (2022). Kinerja Keuangan Perusahaan Farmasi BUMN dan Non-BUMN Sebelum dan Selama Pandemi. Owner: Riset & Jurnal Akuntansi, 6(3).
Bani, Z. (2023). Analysis Of Financial Performance Using Economic Value Added (EVA), Market Value Added (MVA), And Financial Value Added (FVA) Methods In PT. Mayora Indah, Tbk Period 2019-2021. International Journal Management and Economic, 2(1), 46–53.
Bhasin, M. Lal. (2017). A Study of Economic Value Added Disclosures in the Annual Reports: Is EVA a Superior Measure of Corporate Performance? East Asian Journal of Business Economics, 5(1), 10–26.
Elaga, M. P., Wahyu, A. D. S., & M. Krisna, A. P. (2018). Analisis Rasio Aktivitas Untuk Menilai Kinerja Keuangan Pada PT Hanjaya Mandala Sampoerna Tbk. SIDJEB: Sriwijaya International Journal of Dynamic Economics and Business, 2(4), 1–11.
Ferry, I., & Manurung, N. Y. (2020). Analisis Economic Value Added (EVA) Dan Market Value Added (MVA) Sebagai Alat Ukur Kinerja Keuangan PT Garuda Indonesia Tbk Tahun 2017-2019. Jurnal Pajak Dan Keuangan Negara, 2(1), 31–45.
Ikatan Akuntan Indonesia. (2021). Manajemen Keuangan Lanjutan Modul Chartered Accountant.
Indofarma.id. (n.d.). https://indofarma.id . Retrieved August 4, 2023, from https://indofarma.id
Irfani, Agus, S. (2020). Manajemen Keuangan Dan Bisnis: Teori Dan Aplikasi. Jakarta: PT. Gramedia.
Kasmir. (2019). Pengantar Manajemen Keuangan (Cetakan Ke-7). Jakarta: Prenadamedia Group.
kemenperin.go.id. (n.d.). www.kemenperin.go.id.
kimiafarma.co.id. (n.d.). https://www.kimiafarma.co.id. Retrieved from https://www.kimiafarma.co.id
Menteri Hukum Dan Hak Asasi Manusia. (2019). Peraturan Pemerintah Republik Indonesia Nomor 76 Tahun 2019 Tentang Penambahan Penyertaan Modal Negara Republik Indonesia Ke Dalam Modal Saham Perusahaan Perseroan (PERSERO) PT Bio Farma .
Menteri Hukum Dan Hak Asasi Manusia. (2020). Undang-Undang RI Nomor 2 Tahun 2020 tentang Penetapan Peraturan Pemerintah Pengganti Undang-Undang Nomor 1 Tahun 2020.
Meutia, D. (2017). Penilaian Kinerja Keuangan Perusahaan Dengan Menggunakan Metode EVA (Economic Value Added) (Studi Kasus pada PT. Krakatau Steel Tbk Periode 2012-2016). Jurnal Manajemen Dan Keuangan, 6(1).
Miske, W., Mahdi, H., & Husin, F. (2021). Perhitungan Biaya Modal Untuk Menganalisa Kinerja Keuangan. Jurnal Ekonomi, Bisnis, Akuntansi Dan Sistem Informasi (EKSISTANSI), 10(1).
Novaya, S. T., & Prima, R. A. , S. (2022). Analisis Financial Distress Dan Financial Performance Sebelum Dan Selama Pandemi COVID-19 Pada Perusahaan Manufaktur. JRAMB: Jurnal Riset Akuntansi Mercu Buana, 8(1).
Nurlinda, & Hermuningsih, S. (2023). Analisis Kinerja Keuangan Perusahaan Farmasi Sebelum Dan Sesudah Pembentukan Holding BUMN Farmasi. CAPITAL: Jurnal Ekonomi Dan Manajemen, 6(2).
PT Indofarma Tbk. (2020). Laporan Tahunan 2020. Jakarta.
PT Indofarma Tbk. (2021). Laporan Tahunan 2021. Jakarta.
PT Indofarma Tbk. (2022). Laporan Tahunan 2022. Jakarta .
PT Kimia Farma Tbk. (2020). Laporan Tahunan 2020. Jakarta.
PT Kimia Farma Tbk. (2021). Laporan Tahunan 2021. Jakarta.
PT Kimia Farma Tbk. (2022). Laporan Tahunan 2021. Jakarta.
Rieke, P. (2020). Analysis of Performance Company: Based on Value Added And Financial Statement. Jurnal Aset (Akuntansi Riset) Program Studi Akuntansi FPEB UPI.
Sumarlin, A. (2020). Pengaruh Economic Value Added (EVA) Dan Market Value Added (MVA) Terhadap Harga Saham PT Kimia Farma Tbk (Persero) Periode 2016-2019. AkMen Jurnal Ilmiah, 17(4), 652–664.
Sunitha, D., Ni, M. S. , W., Putu, R. M., & Lucy, S. , M. (2020). The Impact of COVID-19 Pandemic on the Financial Performance of Firms on the Indonesia Stock Exchange. Journal of Economics, Business, & Accountancy Ventura, 23(2), 226–242.
Warren, Carl, S., James M. Reeve., Jonathan, E. , D., Ersa, T. W., & Amir A. J. (2018). Pengantar Akuntansi 1 (Cetakan Ketiga). Jakarta: Salemba Empat.
Wilda, E. B. (n.d.). Urgensi Holdig BUMN Dalam Peningkatan Sektor Pelayanan Angkutan Darat Dan Udara. Masalah- Masalah Hukum, 47(2), 89–99.
Bila bermanfaat silahkan share artikel ini
Berikan Komentar Anda terhadap artikel Mengukur Kinerja Keuangan Menggunakan Eva dan Rasio Aktivitas Pada Industri Farmasi Setelah Holding BUMN
ARTICLE HISTORY
Issue
Section
Copyright (c) 2023 Rena Mustari Mokoginta
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under Creative Commons Attribution 4.0 International License that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (Refer to The Effect of Open Access).
